Zonera HAssan

About Zonera HAssan

Zonera HAssan, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at Technische Universität München,

His recent articles reflect a diverse array of research interests and contributions to the field:

Corrigendum to" A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer"[Bioorgan. Chem. 119 (2022) 105505]

A unified computational pathology method to quantify HER2 expression from raw IHC and IF images in breast cancer

Abstract P6-04-03: Computational pathology based HER2 expression quantification in HER2-low breast cancer

Abstract P2-09-03: Quantification of HER2 expression and spatial biology using computational pathology: A cross-assay validation study in breast cancer

AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer

Mass spectrometry-based draft of the mouse proteome

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype

Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition

Zonera HAssan Information

University

Position

Klinikum rechts Der Isar

Citations(all)

822

Citations(since 2020)

729

Cited By

336

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

13

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Top articles of Zonera HAssan

Corrigendum to" A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer"[Bioorgan. Chem. 119 (2022) 105505]

Bioorganic chemistry

2024/3/7

A unified computational pathology method to quantify HER2 expression from raw IHC and IF images in breast cancer

Cancer Research

2023/4/4

Zonera Hassan
Zonera Hassan

H-Index: 7

Günter Schmidt
Günter Schmidt

H-Index: 18

Abstract P6-04-03: Computational pathology based HER2 expression quantification in HER2-low breast cancer

Cancer Research

2023/3/1

Zonera Hassan
Zonera Hassan

H-Index: 7

Andrew Livingston
Andrew Livingston

H-Index: 46

Abstract P2-09-03: Quantification of HER2 expression and spatial biology using computational pathology: A cross-assay validation study in breast cancer

Cancer Research

2023/3/1

Zonera Hassan
Zonera Hassan

H-Index: 7

AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer

Cellular and Molecular Life Sciences

2023/1

Zonera Hassan
Zonera Hassan

H-Index: 7

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype

JCI insight

2022/5/5

Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition

Cancer Communications

2022/4

Zonera Hassan
Zonera Hassan

H-Index: 7

RelA is an essential target for enhancing cellular responses to the DNA repair/Ref-1 redox signaling protein and restoring perturbated cellular redox homeostasis in mouse PDAC …

Frontiers in Oncology

2022/3/24

Zonera Hassan
Zonera Hassan

H-Index: 7

Chi Zhang
Chi Zhang

H-Index: 2

HDAC2 facilitates pancreatic cancer metastasis

Cancer research

2022/2/15

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer

Bioorganic Chemistry

2022/2/1

Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties

Neuro-oncology

2021/11/1

Important role of Nfkb2 in the KrasG12D-driven carcinogenesis in the pancreas

Pancreatology

2021/8/1

Zonera Hassan
Zonera Hassan

H-Index: 7

Sebastian Müller
Sebastian Müller

H-Index: 3

Differential sensitivity of mouse PDAC KrasG12D cells to Ref-1/APE1 redox signalling inhibitors: Role of NFkB as a primary target of Ref-1/APE1 in Kras driven …

Cancer Research

2021/7/1

Olivia Babb
Olivia Babb

H-Index: 1

Zonera Hassan
Zonera Hassan

H-Index: 7

The SUMO pathway in pancreatic cancer: insights and inhibition

2021/2/2

Zonera Hassan
Zonera Hassan

H-Index: 7

Ulrich Keller
Ulrich Keller

H-Index: 14

Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC

Molecular oncology

2020/12

Zonera Hassan
Zonera Hassan

H-Index: 7

Ulrich Keller
Ulrich Keller

H-Index: 14

Interaction of MYC and SUMOylation machinery in an aggressive pancreatic cancer subtype

Cancer Research

2020/8/15

Zonera Hassan
Zonera Hassan

H-Index: 7

Ulrich Keller
Ulrich Keller

H-Index: 14

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype

Gut

2020/8/1

Role of NFkB2 and MTOR in Pancreatic Ductal Adenocarcinoma

2020

Zonera Hassan
Zonera Hassan

H-Index: 7

See List of Professors in Zonera HAssan University(Technische Universität München)